We are live on
!
Find out more
AYLA
Ayala Pharmaceuticals, Inc. Common Stock
AYLA
AYLA
Delisted
AYLA was delisted on the 18th of January, 2023.
7 hedge funds and large institutions have $18.8M invested in Ayala Pharmaceuticals, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
5% more capital invested
Capital invested by funds: $17.9M → $18.8M (+$850K)
0% more funds holding
Funds holding: 7 → 7 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Holders
7
Holders Change
–
Holders Change %
0%
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
2
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
SCM
Sio Capital Management
New York
|
+$531K |
| 2 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$141K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$5.37K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$4.88K |
Top Sellers
| 1 |
ZP
Zimmer Partners
New York
|
-$1.26M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$657K |
| 3 |
Millennium Management
New York
|
-$297K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$34K |
| 5 |
1W
1776 Wealth
Atlanta,
Georgia
|
-$1K |